Source comparison
NAD+ Precursors vs Direct NAD+ Administration
Oral NAD+ precursors. Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Enter cells and convert to NAD+ via the salvage pathway. NR requires one enzymatic step (nicotinamide riboside kinase), while NMN requires two (conversion to NR, then phosp
This comparison does not assign a generated winner or score.
- Oral NAD+ precursors. Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN). Enter cells and convert to NAD+ via the salvage pathway. NR requires one enzymatic step (nicotinamide riboside kinase), while NMN requires two (conversion to NR, then phosphorylation). Direct oral NAD+ is largely degraded in the GI tract before absorption; studies using isotope-labeled NAD+ show less than 5% reaches systemic circulation intact. IV NAD+ bypasses gut degradation entirely, delivering the coenzyme directly to plasma where tissues take it up via CD38 and CD73 receptors.
- The dosing divergence exists because bioavailability differs by route. Oral NMN at 300mg produces roughly 50–80µM peak plasma NAD+ elevation within 90 minutes, sustained for 4–6 hours. IV NAD+ at 100mg produces 200–400µM peak concentrations within 15 minutes, but clears within 2 hours due to rapid cellular uptake and enzymatic conversion. For sustained metabolic support, oral precursors are dosed daily; IV protocols run weekly or biweekly.
- Research shows NMN crosses cell membranes more efficiently than NR in certain tissues. Particularly skeletal muscle and liver. A 2022 study in Nature Metabolism found 250mg oral NMN increased hepatic NAD+ by 26% and reduced circulating triglycerides by 18% in participants with NAFLD, while equivalent-dose NR showed 14% hepatic increase. The mechanistic difference: NMN may utilize a dedicated transporter (Slc12a8) that NR does not. At Real Peptides, researchers often ask which precursor best supports their specific metabolic target. Muscle biogenesis favors NMN, while neuronal NAD+ restoration may favor NR due to better blood-brain barrier penetration.